Yip TCF et al. Tenofovir treatment has lower risk of hepatocellular carcinoma than entecavir treatment in patients with chronic hepatitis B. (Abstract LB-03),Choi J et al. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study. JAMA Oncol. 2019;5:30-6.
Rilpivirine remt leverfibrose door selectieve STAT1-gemedieerde apoptose van hepatische stellaatcellen
apr 2020 | Hepatologie, HIV, Virale infecties